Conformis Inc Receivables Turnover Ratio (CFMS), from the second quarter 2023 to the second quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Conformis inc   (CFMS)
 

Conformis Inc Accounts Receivables Turnover Ratio from the second quarter 2023 to the second quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Conformis Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2023 to a ratio of 6.43, this is below the company average, and notable indication of worsening business environment. Average collection period, for Conformis Inc 's accounts receivable remained unchanged at 57 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 305 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 1707 to 2363.

What is Receivable Turnover Ratio?
What is Conformis Inc Selling?


What is Receivable Turnover Ratio?





CFMS Receivables Turnover Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Receivable Change -19.52 % -15.65 % 7.64 % 5.92 % 7.13 %
Y / Y Revenue Change -14.85 % -17.45 % 12.94 % -3.29 % -72.86 %
Receivable Turnover Ratio (TTM) 6.43 6.36 6.38 6.28 6.42
CFMS's Total Ranking # 2363 # 1707 # 1707 # 2237 # 1871
Accounts Receivable average collection period days 57 57 57 58 57
Seq. Receivable Change -10.24 % -12.49 % 3.18 % -0.69 % -5.93 %
Seq. Revenue Change 1.45 % -26.31 % 26.38 % -9.88 % -1.65 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 107
Healthcare Sector # 306
Overall Market # 2363

Receivable Turnover Ratio Statistics
High Average Low
11.9 7.29 5.59
(Jun 30 2021)   (Sep 30 2016)






Financial Statements
Conformis Inc 's Accounts Receivable $ 8 Millions Visit CFMS's Balance sheet
Conformis Inc 's Sales TTM $ 57 Millions Visit CFMS's Income Statement
Sources of CFMS's Revenues Visit CFMS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CFMS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CFMS's Growth Rates CFMS's Roa CFMS's Inventory Turnover Ratio CFMS's Dividend Comparisons
CFMS's Profitability Ratios CFMS's Roi CFMS's Asset Turnover Ratio CFMS's Dividend Growth
CFMS's Valuation Ratios CFMS's Roe CFMS's Financial Strength Ratios CFMS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Receivable at quarter ending Jun 30 2023
Kiniksa Pharmaceuticals International Plc  20.10 $ 280.837  Millions$ 13.973  Millions
Lftd Partners Inc   19.95 $ 47.535  Millions$ 2.383  Millions
U S Physical Therapy Inc  19.88 $ 350.308  Millions$ 17.621  Millions
Caribou Biosciences Inc   19.67 $ 14.252  Millions$ 0.724  Millions
Telesis Bio Inc   19.14 $ 95.322  Millions$ 4.982  Millions
Ainos Inc   18.81 $ 2.874  Millions$ 0.153  Millions
Neuroone Medical Technologies Corp  18.25 $ 1.279  Millions$ 0.070  Millions
Qhslab Inc   18.25 $ 1.295  Millions$ 0.071  Millions
Cue Health Inc   18.24 $ 251.027  Millions$ 13.759  Millions
Anika Therapeutics Inc   18.00 $ 161.782  Millions$ 8.990  Millions
Xoma Royalty Corporation  17.45 $ 4.032  Millions$ 0.231  Millions
Clearside Biomedical Inc   17.12 $ 1.618  Millions$ 0.095  Millions
Precigen Inc   16.81 $ 22.103  Millions$ 1.315  Millions
Chemed Corporation  16.35 $ 2,187.099  Millions$ 133.800  Millions
Inovio Pharmaceuticals Inc   16.34 $ 17.250  Millions$ 1.056  Millions
China Health Industries Holdings Inc   16.15 $ 0.112  Millions$ 0.007  Millions
Nektar Therapeutics  16.07 $ 87.741  Millions$ 5.461  Millions
Nutriband Inc   15.67 $ 2.278  Millions$ 0.145  Millions
Titan Pharmaceuticals Inc   15.53 $ 0.396  Millions$ 0.026  Millions
Palvella Therapeutics Inc   15.36 $ 33.207  Millions$ 2.161  Millions
Cano Health Inc   15.17 $ 2,978.861  Millions$ 196.310  Millions
Patterson Companies Inc   14.80 $ 6,524.261  Millions$ 440.919  Millions
Petvivo Holdings Inc   14.70 $ 0.976  Millions$ 0.066  Millions
Invo Fertility Inc   14.58 $ 1.177  Millions$ 0.081  Millions
Protalix Biotherapeutics inc   14.52 $ 67.463  Millions$ 4.648  Millions
Rvl Pharmaceuticals Plc  14.22 $ 35.973  Millions$ 2.531  Millions
C4 Therapeutics Inc   14.20 $ 16.031  Millions$ 1.129  Millions
Thorne Healthtech Inc   14.18 $ 255.948  Millions$ 18.044  Millions
Marizyme Inc   13.96 $ 0.485  Millions$ 0.035  Millions
Arrowhead Pharmaceuticals Inc   13.94 $ 256.213  Millions$ 18.375  Millions

Date modified: 2026-10-07T00:41:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.